Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.11.03.467050

Significant Subgraph Mining for Neural Network Inference with Multiple Comparisons Correction

Abstract

We describe how the recently introduced method of significant subgraph mining can be employed as a useful tool in network comparison. It is applicable whenever the goal is to compare two sets of unweighted graphs and to determine differences in the processes that generate them. We provide an extension of the method to dependent graph generating processes as the occur for example in within-subject experimental designs. Furthermore, we present an extensive investigation of error-statistical properties of the method in simulation using Erd[o]s-Renyi models and in empirical data. In particular, we perform an empirical power analysis for transfer entropy networks inferred from resting state MEG data comparing autism spectrum patients with neurotypical controls. From this analysis one may estimate that the appropriate sample size for similar studies should be chosen in the order of n=60 per group or larger. Author summaryA key objective of neuroscientifc research is to determine how different parts of the brain are connected. The end result of such investigations is always a graph consisting of nodes corresponding to brain regions or nerve cells and edges between the nodes indicating if they are connected or not. The connections may be structural (an actual anatomical connection) but can also be functional - meaning that there is a statistical dependency between the activity in one part of the brain and the activity in another. A prime example of the latter type of connection would be the information flow between brain areas. Differences in the patterns of connectivity are likely to be responsible for and indicative of various neurological disorders such as autism spectrum disorders. It is therefore important that efficient methods to detect such differences are available. The key problem in developing methods for comparing patterns of connectivity is that there is generally a vast number of different patterns (it can easily exceed the number of stars in the milky way). In this paper we describe how the recently developed method of significant subgraph mining accounts for this problem and how it can be usefully employed in neuroscientifc research.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gutknecht, A., Wibral, M.. 2021-11-04. Significant Subgraph Mining for Neural Network Inference with Multiple Comparisons Correction. https://doi.org/10.1101/2021.11.03.467050

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗